|
Volumn 42, Issue 1, 2016, Pages 11-12
|
Bacteriophage therapy: Fast-forward to the past lessons identified from the advanced therapy regulation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BIOLOGICAL PRODUCT;
ANTIBIOTIC RESISTANCE;
BACTERIOPHAGE;
BACTERIOPHAGE THERAPY;
CLINICAL EFFECTIVENESS;
EDITORIAL;
HUMAN;
KERATINOCYTE;
NONHUMAN;
PATIENT SAFETY;
PRACTICE GUIDELINE;
VIROTHERAPY;
BIOLOGICAL THERAPY;
BURNS;
CELL CULTURE;
CELL TRANSPLANTATION;
EUROPE;
GOVERNMENT REGULATION;
LEGISLATION AND JURISPRUDENCE;
TRANSPLANTATION;
BACTERIOPHAGES;
BIOLOGICAL PRODUCTS;
BIOLOGICAL THERAPY;
BURNS;
CELL TRANSPLANTATION;
CELLS, CULTURED;
EUROPE;
GOVERNMENT REGULATION;
HUMANS;
KERATINOCYTES;
|
EID: 84954286746
PISSN: 03054179
EISSN: 18791409
Source Type: Journal
DOI: 10.1016/j.burns.2015.10.022 Document Type: Editorial |
Times cited : (4)
|
References (4)
|